Ashland loss narrows on growth in life sciences businessFeb 3, 2026Ashland narrowed its full-year adjusted EBITDA guidance while reporting reduced losses due to growth in its life sciences business.Ashland loss narrows on growth in life sciences businesschemweekTopic tracking2025-10-30Adama’s Net Loss Narrows on Flat Sales2025-11-12Bayer net loss narrows; operating profit rises, beats estimates2026-02-03Ashland loss narrows on growth in life sciences business2026-06-16Business Watch: Investor seeks Ashland sale; WuXi sues the Pentagon
ChemBrief